DIA

🚀 Exhibit at DIA Global Annual Meeting 🌍 🔹 Connect with top industry leaders and key decision-makers. 🔹 Showcase your innovative products and services to a global audience. 🔹 Collaborate with experts to drive impactful solutions. 🔹 Grow your brand visibility and expand your network in the life sciences space. Don’t miss this opportunity to position your company at the forefront of medical product development. Secure your booth today! https://ow.ly/BUNG50UyUr2 #LifeSciences #ExhibitWithUs #GlobalAnnualMeeting #Innovation #Networking

We are excited to share this list of distinguished experts who will be speaking at the upcoming 2025 Combination Products in the EU on 28-29 January 2025 at the Radisson Grand Place in Brussels, Belgium. They will be addressing vital topics that will help drive future EU innovation. Join them to explore the current challenges and to drive solutions for pragmatic implementation: 🔹 Natalie Batty, Senior Regulatory Affairs Specialist, Aignostics 🔹 Marina Belonogova, Associate Director, GRA Diagnostics & Digital Health, Johnson & Johnson Innovative Medicine 🔹 Gert Bos, PhD, FRAPS, Executive Director & Partner, CEO Qserve China, Qserve Group B.V. 🔹 Christelle Bouygues, Regulatory Affairs Senior Officer, European Medicines Agency (EMA) 🔹 Tim Chesworth, Senior Director Regulatory Affairs, AstraZeneca 🔹 Sebastian Fischer, Regulatory Strategy Principal, TÜV-SÜD, Germany 🔹 Ruth Foster, Director Medical Device and Digital Health, EMEA, MSD 🔹 Sabina Hoekstra-van den Bosch, PharmD FRAPS, Global Director Regulatory Strategy, TÜV SÜD 🔹 Amanda Matthews, Executive Director, Head of Regulatory for Combination Products & Medical Devices, Pfizer 🔹 Thomas W. Møller, Director Global Regulatory Affairs - Devices, Novo Nordisk 🔹 Ola Oyinloye, RAC, Director CMC Regulatory Affairs and Devices, Platform and Portfolio, Novo Nordisk 🔹 Benjamin Rochette, Vice President, Global Regulatory Affairs, Coloplast 🔹 Fabien Roy, Partner, Hogan Lovells 🔹 Jonathan Sutch, Principal Medicinal Technical Specialist, BSI Group 🔹 Sophie Tabutin, EMEA Regulatory Affairs Leader, W.L. Gore 🔹 Anja Wiersma PhD, CEO and Senior Consultant, mi-CE consultancy Regulatory Affairs Professionals Society (RAPS) Meet them in Brussels! Save your seat today: https://bit.ly/3YQak2c.

Make Plans for 2025. Connect with peers and experts, and stay informed on the critical issues shaping the future of healthcare with our upcoming events!📆 Global Pharmacovigilance and Risk Management Strategies Conference January 27-29 | Baltimore, MD https://ow.ly/Wn9M50UtIvz Regulatory Submissions, Information, and Document Management Forum February 3-5 | North Bethesda, MD https://ow.ly/LCBF50UtIvu Advertising and Promotion Regulatory Affairs Conference February 24-25 | Bethesda, MD https://ow.ly/39Sx50UtIvq Executive Roundtable: Shaping the Future of Obesity Drug Development February 20 | Gaithersburg, MD https://ow.ly/vXZO50UtIvA Medical Affairs and Scientific Communications Forum March 10-12 | Boston, MA https://ow.ly/XUog50UtIvx Global Labeling Conference April 7-8, 2025 | Arlington, VA https://ow.ly/Fqs650UtIvv Biostatistics and Clinical Innovation Industry and Regulator Forum April 28- 29 | Bethesda, MD https://ow.ly/kIQi50UtIvt DIA/USP Evolution of Biosimilars Development Workshop May 20-21 | Rockville, MD https://ow.ly/8wVC50UtIvr

The DIAmond sessions at #DIAEurope2025 bring together global experts to address some of the most pressing challenges in the life sciences field. Engage in thought-provoking discussions on topics such as environmental sustainability in healthcare, the future of the EU pharma legislation, patient engagement in product development, Europe’s role in the global digitalisation of medicine regulation, and harmonisation of global regulatory standards. Don’t miss the chance to be part of the conversation and drive change. Swipe left to explore what’s in store and secure your spot by 16 January to take advantage of the advance rates. ◾ Learn more about the DIAmond sessions: https://bit.ly/3Ph1Jju. ◾ Register today: https://bit.ly/4aN1NA1. #DIAmondSessions #LifeSciences #HealthcareInnovation #GlobalHealth

🚨 Pre-sale tickets are SOLD OUT! 🚨 You were quick, and we loved the enthusiasm—but don’t worry if you missed out on pre-sale tickets! Early Bird tickets are still available until February 13th! An early bird ticket is your last chance to secure a discounted spot at the DIA Global Annual Meeting and join industry leaders, experts from academia, and regulators as we explore the latest advancements in medical product development and the impact across the pharmaceutical sector. 🔥 Why you don’t want to miss this: Cutting-edge insights Network with top professionals and thought leaders shaping the future of medical product development Gain actionable knowledge that can drive success for you and your organization 👉 Register today and be part of the conversation that’s transforming the industry. https://ow.ly/SV4Q50Uvq88

🚨 Clinical Operations Professionals: DIA Global Annual Meeting 2025 is a Must-Attend! 🚨 Managing clinical trials has never been more complex. Patient recruitment delays, data management issues, and shifting regulatory requirements are challenges you know all too well. Join us at the DIA Global Annual Meeting 2025 to collaborate with global leaders and find actionable solutions to these pressing problems. 🔑 What to Expect: Solve recruitment & retention issues: Discover strategies to recruit the right patients faster and retain them through the study. Stay ahead of regulatory complexity: Gain insights on FDA, EMA, ICH GCP compliance to reduce risks and avoid delays. Improve trial efficiency: Streamline trial design and operations for cost-saving, faster delivery. Master data management: Learn new technologies for accurate and timely analysis of diverse data types. 📅 Don’t miss out—register now to secure your seat at the premier event for clinical operations professionals. Let’s tackle these challenges together! https://ow.ly/ANhi50UvcU1 #DIA2025 #ClinicalOperations #ClinicalTrials #RegulatoryCompliance #PatientRecruitment #DataManagement

Join the DIA-US FDA Biosimilars Workshop, 3-4 February in Hyderabad, to gain valuable insights into the development and lifecycle management of biosimilars. Key highlights: ◾ Hear directly from FDA experts on regulatory requirements and industry best practices. ◾ Expand your knowledge on clinical data, post-approval changes, and inspections. ◾ Network with leading professionals from across the biosimilars field. We are proud to host esteemed FDA subject matter experts who will share their insights on biosimilar medicines and address your questions directly during the workshop. The early bird ends on 13 January. Secure your spot today to benefit from the lowest fee: https://bit.ly/3DvqS7t. #DIAUSFDAWorkshop25 #Biosimilars #RegulatoryAffairs #Learning

Both Regulatory Affairs Professionals Society (RAPS) and DIA are counting the days until we all gather again in Brussels on 28-29 January. We’ll be building upon last year’s highly successful inaugural event. There is no better venue to connect with representatives from EMA, the European Commission, Notified Bodies, National Competent Authorities and Industry. Some of the topics we will cover: ✔️Article 117 of the MDR ✔️Rule 14 of the MDR ✔️Rule 21 of the MDR ✔️New EU General Pharmaceutical Legislation ✔️Updates and the latest EMA guidance ✔️Updates on COMBINE for Combination Products and Diagnostics and much more Meet us in Brussels! Save your seat today: https://bit.ly/3YQak2c.

Thank You for Joining Us! We hosted a round table in our D.C. office today – Innovating Together: Tackling Global Challenges in Developing, Manufacturing, and Distributing Safe, Effective, and High-Quality Medicines moderated by Zili Li, MD, MPH, DIA Fellow and Board Member. A huge thank you to our distinguished speakers, panelists, and attendees for your insights, expertise, and shared commitment to improving global access to quality medicines. Highlights Special guest remarks from BI Jingquan (CCIEE) and Mark Abdoo (FDA) set the tone for impactful discussions. A thought-provoking panel explored priority areas for global collaboration, including regulatory harmonization and innovation in medicine development. Networking lunch fostered new connections across regulatory, industry, academic, and nonprofit sectors. A Special Thanks To Our panelists from leading organizations like Johnson & Johnson, Eli Lilly, Novartis, and USP. The CCIEE delegation for their valuable contributions and perspectives. This roundtable reinforced the importance of partnerships in advancing patient access to safe and effective medicines worldwide. Let’s keep the momentum going! 💡 Next Steps: We’re excited to explore actionable initiatives and continue this dialogue at future events. Stay tuned! #GlobalHealth #PharmaInnovation #Collaboration #DIA #TogetherWeInnovate

The Signal Management in Pharmacovigilance training course is back in March and the early bird rate is ending soon! By joining this Training Course, you will have the chance to benefit from the hands-on experience of trainers who have worked for many years in signaling activities. The instructors will cover: ◾ All the main concepts behind signal detection and signal management including the data mining techniques for a large volume of ADR data analysis. ◾ The EU legislation related to signal management, as well as the regulatory expectations in other countries such as the US, Switzerland, Canada, and Australia. ◾ Strategies to implement signal management processes in your own organisation. Register until 7 January to benefit from our early bird rate: https://bit.ly/3ZZQS3K. Jose Alberto Ayala Ortiz #Signal25 #Pharmacovigilance #DrugSafety #SignalManagement #GVP